ACTL7A新型双等位基因变异与男性不育及完全受精失败相关
研究在一个因完全受精失败(TFF)导致男性不育的非近亲家系中,通过全外显子测序鉴定出ACTL7A新型复合杂合变异(c.[463C>T];[1084G>A],p.[(Arg155Ter)];[(Gly362Arg)]),并发现该变异导致顶体及核周膜超微结构缺陷、ACTL7A与磷脂酶C zeta蛋白表达显著降低,提示卵母细胞激活缺陷;经钙离子载体(A23187)行人工卵母细胞激活后成功获得活产。
要点
- ACTL7A复合杂合变异被鉴定为人类完全受精失败(TFF)的致病遗传因素。
- 该变异导致精子顶体及核周膜超微结构缺陷,并降低ACTL7A与磷脂酶C zeta蛋白表达。
- 钙离子载体(A23187)人工卵母细胞激活成功挽救TFF并获得活产。
核心结论
- ACTL7A双等位基因变异与人类完全受精失败相关,扩展了TFF的遗传谱并支持TFF患者的遗传诊断。
- 钙离子载体(A23187)人工卵母细胞激活为ACTL7A致病变异患者提供了潜在有效的干预手段。
研究设计与样本
- 研究招募了一个非近亲家系,其儿子表现为ICSI后完全受精失败(TFF)的不育。
- 采用全外显子测序鉴定潜在致病变异,Sanger测序验证,并用计算机工具预测致病性。
- 通过透射电子显微镜(TEM)研究精子超微结构,用免疫荧光染色和蛋白质印迹研究变异对精子蛋白表达的影响。
- 对ICSI后实施钙离子载体(A23187)人工卵母细胞激活(AOA)以克服TFF,并随访妊娠结局。
主要发现
- 在该TFF家系中鉴定出ACTL7A新型复合杂合变异c.[463C>T];[1084G>A],p.[(Arg155Ter)];[(Gly362Arg)]。
- 计算机分析预测该变异导致致病性蛋白。
- TEM显示ACTL7A变异导致精子顶体和核周膜超微结构缺陷。
- 与健康对照相比,受影响精子中ACTL7A和磷脂酶C zeta(精子携带的关键卵母细胞激活因子)蛋白表达显著降低。
- ICSI后使用钙离子载体(A23187)行AOA成功挽救TFF,并使该ACTL7A变异患者获得活产。
临床怎么用
- 作者认为,该发现支持对TFF患者进行遗传诊断。
- 作者指出,AOA成功挽救TFF并获得健康活产,为ACTL7A致病变异患者提供了潜在有效的干预手段。
局限性
- 鉴于精子相关TFF的罕见性,仅发现一个携带ACTL7A变异的独生子家系。
- 由于在一次ICSI失败后即介入AOA,未能在两个或以上ICSI周期中评估TFF表型。
- 需在更大独立队列中验证ACTL7A变异及其对男性不育的影响。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
STUDY QUESTION: What are the genetic causes of total fertilization failure (TFF) in a proband suffering from male infertility? SUMMARY ANSWER: Novel compound heterozygous variants (c.[463C>T];[1084G>A], p.[(Arg155Ter)];[(Gly362Arg)]) in actin-like protein 7A (ACTL7A) were identified as a causative genetic factor for human TFF. WHAT IS KNOWN ALREADY: ACTL7A, an actin-related protein, is essential for spermatogenesis. ACTL7A variants have been reported to cause early embryonic arrest in humans but have not been studied in human TFF. STUDY DESIGN, SIZE, DURATION: We recruited a non-consanguineous family whose son was affected by infertility characterized by TFF after ICSI. Whole-exome sequencing was used to identify the potential pathogenic variants. Artificial oocyte activation (AOA) after ICSI was performed to overcome TFF and any resulting pregnancy was followed up. PARTICIPANTS/MATERIALS, SETTING, METHODS: Sanger sequencing was performed to validate the variants. Pathogenicity of the identified variants was predicted by in silico tools. The ultrastructure of spermatozoa was studied by transmission electron microscopy (TEM). Immunofluorescence staining and western blotting were used to investigate the mechanism of the variants on the affected spermatozoa. MAIN RESULTS AND THE ROLE OF CHANCE: Novel compound heterozygous variants in ACTL7A (c.[463C>T];[1084G>A], p.[(Arg155Ter)];[(Gly362Arg)]) were identified in a family with TFF after ICSI. In silico analysis predicted that the variants lead to a disease-causing protein. TEM showed that the ACTL7A variants caused ultrastructural defects in the acrosome and perinuclear theca. Protein expression of ACTL7A and phospholipase C zeta, a key sperm-borne oocyte activation factor, was significantly reduced in the affected sperm compared to healthy controls, suggesting that the ACLT7A variants lead to an oocyte activation deficiency and TFF. AOA by calcium ionophore (A23187) after ICSI successfully rescued the TFF and achieved a live birth for the patient with ACTL7A variants. LIMITATIONS, REASONS FOR CAUTION: Given the rarity of sperm-associated TFF, only one family with an only child carrying the ACTL7A variants was found. In addition, the TFF phenotype was not assessed in two or more ICSI cycles, due to the intervention in ICSI with AOA after one failed ICSI cycle. Further studies should validate the ACTL7A variants and its effect on male infertility in larger independent cohorts. WIDER IMPLICATIONS OF THE FINDINGS: : Our findings revealed a critical role of ACTL7A in male fertility and identified bi-allelic variants in ACTL7A associated with human TFF, which expands the genetic spectrum of TFF and supports the genetic diagnosis of TFF patients. We also rescued TFF by AOA and obtained a healthy live birth, which provides a potentially effective intervention for patients with ACTL7A pathogenic variants. STUDY FUNDING/COMPETING INTEREST(S): This work was supported by the National Natural Science Foundation of China (81971374 and 81401267). No conflicts of interest were declared. TRIAL REGISTRATION NUMBER: N/A.
引用
- Wang J, Zhang J, Sun X, et al. Novel bi-allelic variants in ACTL7A are associated with male infertility and total fertilization failure. Hum Reprod. 2021. PMID: 34727571. doi:10.1093/humrep/deab228
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。